ebomi
Colour theme
Sign in
Insider · CIK 0001438226

Schulman AMY W

CIK 0001438226 Name as filed on the most recent filing

Filed as Schulman AMY W (13)

36 transaction lines · from 13 filings · filed 2012-12-07 to 2026-03-23 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

32 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

Transactions filed by this insider
Direction Date Issuer Code Shares Price Value USD Filing
2026-03-12 Elevance Health, Inc.
ELV 		S, Open-market sale 26 disposed 287.50 7,475.00 Form 4, filing 0001438226-26-000007
2025-09-11 Camp4 Therapeutics Corp
CAMP 		P, Open-market purchase 1,221,721 acquired 1.53 1,869,233.13 Form 4, filing 0001193125-25-201392
2025-09-11 Camp4 Therapeutics Corp
CAMP 		P, Open-market purchase 85,468 acquired 1.53 130,766.04 Form 4, filing 0001193125-25-201392
2025-03-13 Fractyl Health, Inc.
GUTS 		P, Open-market purchase 8,550 acquired 1.17 9,964.17 Form 4, filing 0000950170-25-040466
2024-10-15 Camp4 Therapeutics Corp
CAMP 		P, Open-market purchase 909,090 acquired 11.00 9,999,990.00 Form 4, filing 0000950170-24-116360
2024-10-15 Camp4 Therapeutics Corp
CAMP 		P, Open-market purchase 909,090 acquired 11.00 9,999,990.00 Form 4, filing 0000950170-24-114788
2024-06-25 Alnylam Pharmaceuticals, Inc.
ALNY 		S, Open-market sale 8,500 disposed 240.00 2,040,000.00 Form 4, filing 0001735276-24-000072
2024-05-29 Alnylam Pharmaceuticals, Inc.
ALNY 		S, Open-market sale 11,516 disposed 148.93 1,715,077.88 Form 4, filing 0001735276-24-000058
2024-05-29 Alnylam Pharmaceuticals, Inc.
ALNY 		S, Open-market sale 10,121 disposed 148.21 1,500,033.41 Form 4, filing 0001735276-24-000058
2024-05-29 Alnylam Pharmaceuticals, Inc.
ALNY 		S, Open-market sale 63 disposed 149.76 9,434.88 Form 4, filing 0001735276-24-000058
2021-12-13 SQZ Biotechnologies Co
SQZ 		P, Open-market purchase 1,850 acquired 10.94 20,239.00 Form 4, filing 0001209191-21-069790
2021-12-13 SQZ Biotechnologies Co
SQZ 		P, Open-market purchase 1,850 acquired 10.88 20,128.00 Form 4, filing 0001209191-21-069790
2020-11-03 SQZ Biotechnologies Co
SQZ 		P, Open-market purchase 233,654 acquired 16.00 3,738,464.00 Form 4, filing 0000899243-20-030318
2020-11-03 SQZ Biotechnologies Co
SQZ 		P, Open-market purchase 16,346 acquired 16.00 261,536.00 Form 4, filing 0000899243-20-030318
2019-04-08 Cyclerion Therapeutics, Inc.
CYCN 		P, Open-market purchase 604,482 acquired 16.00 9,671,712.00 Form 4, filing 0001209191-19-024236
2019-04-08 Cyclerion Therapeutics, Inc.
CYCN 		P, Open-market purchase 21,635 acquired 16.00 346,160.00 Form 4, filing 0001209191-19-024236
2013-05-15 Pfizer Inc
PFE 		S, Open-market sale 10,598 disposed 29.35 311,051.30 Form 4, filing 0001225208-13-012578
2013-05-15 Pfizer Inc
PFE 		S, Open-market sale 10,408 disposed 29.41 306,099.28 Form 4, filing 0001225208-13-012578
2013-05-15 Pfizer Inc
PFE 		S, Open-market sale 5,700 disposed 29.32 167,124.00 Form 4, filing 0001225208-13-012578
2013-05-15 Pfizer Inc
PFE 		S, Open-market sale 5,268 disposed 29.34 154,563.12 Form 4, filing 0001225208-13-012578
2013-05-15 Pfizer Inc
PFE 		S, Open-market sale 4,701 disposed 29.40 138,209.40 Form 4, filing 0001225208-13-012578
2013-05-15 Pfizer Inc
PFE 		S, Open-market sale 4,500 disposed 29.29 131,805.00 Form 4, filing 0001225208-13-012578
2013-05-15 Pfizer Inc
PFE 		S, Open-market sale 3,999 disposed 29.36 117,410.64 Form 4, filing 0001225208-13-012578
2013-05-15 Pfizer Inc
PFE 		S, Open-market sale 3,807 disposed 29.37 111,811.59 Form 4, filing 0001225208-13-012578
2013-05-15 Pfizer Inc
PFE 		S, Open-market sale 3,802 disposed 29.39 111,740.78 Form 4, filing 0001225208-13-012578
2013-05-15 Pfizer Inc
PFE 		S, Open-market sale 3,800 disposed 29.30 111,340.00 Form 4, filing 0001225208-13-012578
2013-05-15 Pfizer Inc
PFE 		S, Open-market sale 3,592 disposed 29.42 105,676.64 Form 4, filing 0001225208-13-012578
2013-05-15 Pfizer Inc
PFE 		S, Open-market sale 2,400 disposed 29.31 70,344.00 Form 4, filing 0001225208-13-012578
2013-05-15 Pfizer Inc
PFE 		S, Open-market sale 2,259 disposed 29.33 66,256.47 Form 4, filing 0001225208-13-012578
2013-05-15 Pfizer Inc
PFE 		S, Open-market sale 2,005 disposed 29.43 59,007.15 Form 4, filing 0001225208-13-012578
2013-05-15 Pfizer Inc
PFE 		S, Open-market sale 1,956 disposed 29.38 57,467.28 Form 4, filing 0001225208-13-012578
2013-05-15 Pfizer Inc
PFE 		S, Open-market sale 805 disposed 29.44 23,699.20 Form 4, filing 0001225208-13-012578
2013-05-15 Pfizer Inc
PFE 		S, Open-market sale 300 disposed 29.46 8,838.00 Form 4, filing 0001225208-13-012578
2013-05-15 Pfizer Inc
PFE 		S, Open-market sale 100 disposed 29.45 2,945.00 Form 4, filing 0001225208-13-012578
2013-02-06 Zoetis Inc.
ZTS 		P, Open-market purchase 5,000 acquired 26.00 130,000.00 Form 4, filing 0001209191-13-007385
2012-12-06 Pfizer Inc
PFE 		S, Open-market sale 100,000 disposed 25.56 2,555,930.00 Form 4, filing 0001225208-12-024844

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase

Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 8
  • Open-market sale 24
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. SCHULMAN AMY W, insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001438226

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.